Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what medications have been reimbursed to community pharmacies below the market price for pharmacy procurement in (a) 2021, (b) 2022, (c) 2023 and (d) 2024.

The information requested is not held centrally. Community pharmacy reimbursement arrangements, set out in the Drug Tariff, are not designed to pay every individual pharmacy the cost, or more than the cost, of the medicine. This means that at an individual level, there will be instances where a pharmacy pays more than they are reimbursed, and other instances where they are paid less than they are reimbursed.

The medicine margin survey assesses the amount of medicine margin, the difference between the reimbursement price and the price the pharmacy was charged by the supplier, retained by community pharmacies. The survey has found that overall, more than the amount agreed as part of the Community Pharmacy Contractual Framework, has been delivered in total across the previous four financial years.

In addition to this, where a number of pharmacies cannot purchase at or below the Drug Tariff reimbursement price, the Department considers concessionary price requests that come directly from the Community Pharmacy England, on behalf of community pharmacies. From 1 April 2024, we introduced a new retrospective top-up payment for concessionary prices, providing an additional payment to contractors when the margin survey indicates that despite a concessionary price, there was an under payment.